Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1, 2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1, 2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines(771 views) Desplat V, Vincenzi M, Lucas R, Moreau S, Savrimoutou S, Pinaud N, Lesbordes J, Peyrilles E, Marchivie M, Routier S, Sonnet P, Rossi F, Ronga L, Guillon J
Univ. Bordeaux, UFR des Sciences Pharmaceutiques, Cellules Souches Hematopoietiques Normales et Leucemiques, Bordeaux cedex, France
INSERM U1035, Cellules Souches Hématopoïétiques Normales et Leucémiques, Bordeaux, France
INSERM U1212, UMR, CNRS 5320, ARNA Laboratory, Bordeaux, France
Department of Pharmacy, CIRPeB, University of Naples Federico II, Via Mezzocannone, Naples, Italy
Univ. Bordeaux, ISM, CNRS, UMR 5255, 351 cours de la Libération, Talence cedex, France
Univ. Bordeaux, ICMCB, CNRS, UPR 9048, 87, Avenue du Docteur Schweitzer, Pessac cedex, France
Institut de Chimie Organique et Analytique, Univ. Orleans, CNRS, UMR 7311, ICOA, BP 6759, rue de Chartres, Orléans cedex 2, France
Université de Picardie Jules Verne, Laboratoire de Glycochimie, des Antimicrobiens et des Agroressouces, UMR, CNRS 7378, UFR de Pharmacie, 1 rue des Louvels, Amiens cedex 01, France
References: Not available.
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1, 2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1, 2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines
No results.
Synthesis and evaluation of the cytotoxic activity of novel ethyl 4-[4-(4-substitutedpiperidin-1-yl)]benzyl-phenylpyrrolo[1, 2-a]quinoxaline-carboxylate derivatives in myeloid and lymphoid leukemia cell lines